| Aksjer | 585,25 Mrd. | — | KO KoAct | 0,00 | Helsevesen | | 3.8.2023 | 21 596,80 | 8,05 | 37,04 |
TE | Aksjer | 262,7 Mrd. | — | TE Tiger ETF | 0,40 | Helsevesen | KRX Bio K-New Deal Index - KRW - Benchmark TR Gross | 7.10.2020 | 6 714,16 | 6,03 | 51,44 |
KO | Aksjer | 207,3 Mrd. | — | KO KODEX | 0,45 | Helsevesen | FnGuide Bio Index - Benchmark TR Gross | 13.5.2016 | 7 571,40 | 5,44 | 37,93 |
TE | Aksjer | 140,3 Mrd. | — | TE Tiger ETF | 0,40 | Helsevesen | KRX Healthcare - KRW | 18.7.2011 | 34 209,47 | 4,63 | 39,62 |
TE | Aksjer | 103,8 Mrd. | — | TE Tiger ETF | 0,30 | Helsevesen | NASDAQ / Biotechnology | 27.8.2014 | 34 169,74 | 4,88 | 21,01 |
| Aksjer | 71,7 Mrd. | — | KR KB RISE | 0,00 | Helsevesen | KRX Bio Top 10 Index - KRW - Benchmark TR Gross | 24.12.2024 | 15 679,68 | 9,56 | 68,04 |
KO | Aksjer | 68,9 Mrd. | — | KO KODEX | 0,09 | Helsevesen | KRX Healthcare - KRW | 28.3.2017 | 15 543,37 | 4,63 | 39,65 |
KO | Aksjer | 61,4 Mrd. | — | KO KODEX | 0,25 | Helsevesen | S&P Health Care Select Sector | 21.3.2023 | 13 619,17 | 4,86 | 22,50 |
TE | Aksjer | 51,7 Mrd. | — | TE Tiger ETF | 0,40 | Helsevesen | KOSDAQ 150 Biotech Index - KRW - Benchmark TR Gross | 15.12.2016 | 10 546,29 | 10,44 | 59,10 |
SP | Aksjer | 47,68 Mrd. | 9,05 M | SP SPDR | 0,08 | Helsevesen | S&P Health Care Select Sector | 16.12.1998 | 181,29 | 4,86 | 22,63 |
TE | Aksjer | 44,5 Mrd. | — | TE Tiger ETF | 0,45 | Helsevesen | Indxx Global Obesity Treatment Top 2 Plus index - KRW - Benchmark Price Return | 29.2.2024 | 10 059,99 | 7,96 | 17,83 |
KO | Aksjer | 42,66 Mrd. | — | KO KODEX | 0,45 | Helsevesen | iSelect Global Obesity Treatment TOP2 Plus Index - KRW - Benchmark TR Net | 14.2.2024 | 10 794,98 | 5,08 | 12,43 |
TE | Aksjer | 41,8 Mrd. | — | TE Tiger ETF | 0,49 | Helsevesen | Solactive China Biotech Index | 8.12.2020 | 7 525,96 | 4,03 | 28,69 |
TE | Aksjer | 31 Mrd. | — | TE Tiger ETF | 0,40 | Helsevesen | S&P Global 1200 Health Care Custom Index - krw - Benchmark TR Gross | 1.7.2016 | 26 614,79 | 0,00 | 0,00 |
TE | Aksjer | 30,7 Mrd. | — | TE Tiger ETF | 0,40 | Helsevesen | KOSPI 200 Health Care Index - KRW | 23.9.2015 | 18 064,48 | 2,91 | 30,55 |
| Aksjer | 28,45 Mrd. | — | HW Hwabao | 0,60 | Helsevesen | CSI Medical Index Yield - Benchmark TR Gross | 20.5.2019 | 0,34 | 3,08 | 30,88 |
KO | Aksjer | 23 Mrd. | — | KO KODEX | 0,25 | Helsevesen | S&P Biotechnology Select Industry | 31.10.2013 | 43 079,53 | 0,00 | 0,00 |
VA | etf_assetclass_Sector Equity | 21,8 Mrd. | 236 589 | VA Vanguard | 0,09 | Helsevesen | MSCI US IMI 25/50 Health Care | 26.1.2004 | 332,49 | 5,01 | 23,09 |
EF | Aksjer | 17,42 Mrd. | — | EF E Fund | 0,00 | Helsevesen | CSI 300 Medical and Health Index - CNY - Benchmark TR Gross | 9.1.2021 | 0,37 | 3,40 | 26,67 |
NH | Aksjer | 16 Mrd. | — | NH NH-Amundi | 0,00 | Helsevesen | | 26.11.2024 | 14 892,57 | 5,00 | 44,18 |
| Aksjer | 14,21 Mrd. | — | KO KoAct | 0,50 | Helsevesen | | 11.11.2025 | 10 338,06 | 5,59 | 22,65 |
| Aksjer | 12,6 Mrd. | — | KR KB RISE | 0,00 | Helsevesen | FnGuide HealthCare Index - KRW - Benchmark TR Net | 23.9.2016 | 16 773,64 | 4,73 | 37,18 |
IS | Aksjer | 10,73 Mrd. | 1,62 M | IS iShares | 0,44 | Helsevesen | NYSE Biotechnology (TR) | 5.2.2001 | 207,72 | 5,10 | 21,90 |
SP | Aksjer | 10,55 Mrd. | 9,23 M | SP SPDR | 0,35 | Helsevesen | S&P Biotechnology Select Industry | 31.1.2006 | 151,70 | 5,08 | 0,00 |
| Aksjer | 9,16 Mrd. | — | AC ACE | 0,30 | Helsevesen | Solactive Global Big Pharma Index - Benchmark Price Return | 19.11.2024 | 12 860,55 | 7,21 | 21,79 |
KI | Aksjer | 8,41 Mrd. | — | KI Kiwoom | 0,49 | Helsevesen | FnGuide Medical AI Index - KRW - Benchmark TR Gross | 28.5.2024 | 12 779,55 | 0,00 | 0,00 |
| Aksjer | 8,18 Mrd. | — | AC ACE | 0,45 | Helsevesen | Solactive Eli Lilly Value Chain Index - Benchmark Price Return | 19.11.2024 | 12 381,65 | 3,60 | 21,75 |
| Aksjer | 7,94 Mrd. | — | KO KoAct | 0,00 | Helsevesen | | 27.1.2026 | 10 133,67 | 4,34 | 29,64 |
| Aksjer | 6,85 Mrd. | — | KO KoAct | 0,50 | Helsevesen | | 3.9.2024 | 12 841,88 | 4,21 | 17,95 |
BO | Aksjer | 6,66 Mrd. | — | BO Bosera | 0,65 | Helsevesen | Hang Seng Healthcare Index - CNY - Benchmark TR Gross | 18.3.2021 | 0,61 | 2,75 | 12,80 |
CH | Aksjer | 6,37 Mrd. | — | CH ChinaAMC | 0,65 | Helsevesen | Hang Seng Biotech Index - HKD - Benchmark TR Net | 29.9.2021 | 0,82 | 3,00 | 21,32 |
KI | Aksjer | 5,93 Mrd. | — | KI Kiwoom | 0,49 | Helsevesen | Solactive Blockbuster Biotech Drugs Index - CNY - Benchmark TR Net | 28.5.2024 | 11 652,44 | 4,37 | 17,87 |
| Aksjer | 5,69 Mrd. | — | MA Maxwealth | 0,60 | Helsevesen | CSI All-Medical Device Index - CNY - Benchmark TR Gross | 22.4.2021 | 0,49 | 2,64 | 31,06 |
| Aksjer | 5,44 Mrd. | — | NI Nippon | 0,19 | Helsevesen | Nifty Pharma Index - INR - Benchmark TR Gross | 2.7.2021 | 17,49 | 4,59 | 31,47 |
NF | Aksjer | 5,44 Mrd. | — | NF NEXT FUNDS | 0,32 | Helsevesen | | 21.3.2008 | 33 088,93 | 1,86 | 21,64 |
TE | Aksjer | 5,4 Mrd. | — | TE Tiger ETF | 0,50 | Helsevesen | FnGuide Medical Device Index - KRX - Benchmark TR Net | 8.11.2018 | 11 613,78 | 2,77 | 23,45 |
| Aksjer | 5,15 Mrd. | — | KR KB RISE | 0,35 | Helsevesen | KEDI Global Obesity Care Industry Top2+ Index - KRW - Benchmark TR Net | 27.2.2024 | 9 602,93 | 7,72 | 19,09 |
TE | Aksjer | 4,91 Mrd. | — | TE Tiger ETF | 0,40 | Helsevesen | TOPIX-17 PHARMACEUTICAL - JPY | 29.6.2016 | 12 065,00 | 0,00 | 0,00 |
IN | Aksjer | 4,86 Mrd. | — | IN Invesco | 0,00 | Helsevesen | CSI Hong Kong Stock Connect Innovative Drug Index - CNY - Benchmark TR Net | 16.10.2024 | 1,69 | 3,45 | 24,62 |
IC | Aksjer | 4,74 Mrd. | — | IC ICBC | 0,00 | Helsevesen | CSI Hong Kong Stock Connect Innovative Drug Index - CNY - Benchmark TR Net | 26.3.2025 | 1,24 | 0,00 | 0,00 |
IS | Aksjer | 4,51 Mrd. | 737 320 | IS iShares | 0,37 | Helsevesen | Russell 1000 Health Care RIC 22.5/45 Capped Index | 12.6.2000 | 75,37 | 4,86 | 22,76 |
IS | Aksjer | 4,51 Mrd. | 238 809 | IS iShares | 0,38 | Helsevesen | S&P Global 1200 Health Care Sector Capped Index - USD - Benchmark TR Net | 13.11.2001 | 109,21 | 4,19 | 21,81 |
EF | Aksjer | 4,02 Mrd. | — | EF E Fund | 0,00 | Helsevesen | CSI Hong Kong Stock Connect Innovative Drug Index - CNY - Benchmark TR Net | 18.3.2025 | 1,18 | 0,00 | 0,00 |
XT | Aksjer | 3,93 Mrd. | 58 570 | XT Xtrackers | 0,25 | Helsevesen | MSCI World Index / Health Care -SEC | 4.3.2016 | 59,02 | 4,44 | 21,81 |
GU | Aksjer | 3,73 Mrd. | — | GU Guotai | 0,60 | Helsevesen | CSI Biomedical Index - CNY - Benchmark TR Gross | 18.4.2019 | 1,00 | 0,00 | 0,00 |
IS | Aksjer | 3,61 Mrd. | 2,9 M | IS iShares | 0,37 | Helsevesen | DJ US Select / Medical Equipment | 1.5.2006 | 54,94 | 3,79 | 29,41 |
FI | Aksjer | 3,54 Mrd. | 242 985 | FI Fidelity | 0,08 | Helsevesen | MSCI US IMI 25/50 Health Care | 21.10.2013 | 85,95 | 4,77 | 22,64 |
IS | Aksjer | 3,43 Mrd. | 549 742 | IS iShares | 0,15 | Helsevesen | S&P 500 CAPPED 35/20 HEALTH CARE NTR | 20.11.2015 | 14,50 | 4,86 | 22,63 |
FU | Aksjer | 3,15 Mrd. | — | FU Fullgoal | 0,60 | Helsevesen | Hang Seng Hong Kong Stock Connect Healthcare Index - CNY - Chinese Renminbi - Benchmark TR Gross | 14.6.2023 | 1,44 | 0,00 | 0,00 |
FT | etf_assetclass_Sector Equity | 2,98 Mrd. | 76 796 | FT First Trust | 0,55 | Helsevesen | NYSE Arca Biotechnology Index | 19.6.2006 | 269,38 | 3,45 | 22,71 |
NH | Aksjer | 2,73 Mrd. | — | NH NH-Amundi | 0,45 | Helsevesen | iSelect K-MediTech Index - KRW - Benchmark Price Return | 21.12.2023 | 9 115,65 | 3,43 | 26,31 |
| Aksjer | 2,46 Mrd. | — | HW Hwabao | 0,00 | Helsevesen | Hang Seng SCHK Innovative Drug Select Index - HKD - Benchmark TR Gross | — | 4,49 Mrd. | 0,00 | 0,00 |
| Aksjer | 2,31 Mrd. | — | IP ICICI Prudential IETF | 0,13 | Helsevesen | Nifty Healthcare Index - INR - Benchmark TR Gross | 18.5.2021 | 159,17 | 5,10 | 34,66 |
GU | Aksjer | 2,3 Mrd. | — | GU Guotai | 0,60 | Helsevesen | CSI Medical Index Yield - Benchmark TR Gross | 24.12.2020 | 0,42 | 3,08 | 30,90 |
CH | Aksjer | 2,21 Mrd. | — | CH ChinaAMC | 0,75 | Helsevesen | Hang Seng Biotech Index - HKD - Benchmark TR Net | 18.3.2021 | 15,76 | 3,09 | 22,35 |
CH | Aksjer | 2,21 Mrd. | — | CH ChinaAMC | 0,75 | Helsevesen | Hang Seng Biotech Index - HKD - Benchmark TR Net | 18.3.2021 | 15,76 | 3,09 | 22,35 |
HA | Aksjer | 2,15 Mrd. | 355 389 | HA Harvest | 0,85 | Helsevesen | | 18.12.2014 | 7,63 | 5,01 | 23,83 |
PA | Aksjer | 1,82 Mrd. | — | PA Ping An | 0,60 | Helsevesen | CSI Pharmaceutical and Medical Device Innovation Index - CNY - Benchmark TR Gross | 9.6.2021 | 0,36 | 4,13 | 25,07 |
IS | Aksjer | 1,64 Mrd. | 21 698 | IS iShares | 0,41 | Helsevesen | S&P Global 1200 Healthcare Sector Index - AUD | 13.11.2001 | 155,42 | 0,00 | 0,00 |
EF | Aksjer | 1,62 Mrd. | — | EF E Fund | 0,20 | Helsevesen | Yield of China Securities Hong Kong Stock Connect Medical and Health Composite Index - CNY - Benchmark TR Net | 19.1.2022 | 1,11 | 2,50 | 20,25 |
IS | Aksjer | 1,56 Mrd. | 125 182 | IS iShares | 0,40 | Helsevesen | STOXX Global Breakthrough Healthcare (USD)(NR) | 8.9.2016 | 11,04 | 3,82 | 20,92 |
IS | Aksjer | 1,54 Mrd. | 263 399 | IS iShares | 0,37 | Helsevesen | DJ US Select / Pharmaceutical | 1.5.2006 | 102,48 | 4,59 | 21,41 |
AM | Aksjer | 1,49 Mrd. | — | AM Amundi | 0,50 | Helsevesen | MSCI World IMI Virology Select Index - KRW - Benchmark TR Net | 8.6.2022 | 9 937,75 | 2,82 | 14,76 |
EF | Aksjer | 1,45 Mrd. | — | EF E Fund | 0,20 | Helsevesen | China Securities Medical Index - CNY - Benchmark TR Gross | 8.7.2021 | 0,40 | 4,40 | 29,55 |
EF | Aksjer | 1,44 Mrd. | — | EF E Fund | 0,20 | Helsevesen | CSI Biotechnology Theme Index - CNY - Benchmark TR Gross | 14.1.2021 | 0,50 | 2,80 | 29,20 |
IS | Aksjer | 1,4 Mrd. | 579 518 | IS iShares | 0,37 | Helsevesen | DJ US Select / Health Care Providers | 1.5.2006 | 60,36 | 2,30 | 16,34 |
CA | Aksjer | 1,39 Mrd. | — | CA Cathay | 1,05 | Helsevesen | Solactive Global Genomics Immunology and Medical Revolution Index - Benchmark TR Net | 22.11.2021 | 8,22 | 3,39 | 17,66 |
IS | Aksjer | 1,39 Mrd. | 100 797 | IS iShares | 0,40 | Helsevesen | STOXX Global Breakthrough Healthcare (USD)(NR) | 8.9.2016 | 9,85 | 3,82 | 20,92 |
EF | Aksjer | 1,32 Mrd. | — | EF E Fund | 0,20 | Helsevesen | CSI Innovative Drug Industry Index - CNY - Benchmark TR Gross | 3.2.2021 | 0,68 | 3,14 | 28,62 |
GU | Aksjer | 1,31 Mrd. | — | GU Guotai | 0,60 | Helsevesen | SSE STAR Market Innovative Drug Index - CNY - Benchmark TR Gross | 1.8.2025 | 0,95 | 0,00 | 0,00 |
IS | Aksjer | 1,18 Mrd. | 239 254 | IS iShares | 0,35 | Helsevesen | NASDAQ / Biotechnology | 19.10.2017 | 10,19 | 0,00 | 0,00 |
AM | Aksjer | 1,16 Mrd. | 127 | AM Amundi | 0,30 | Helsevesen | MSCI World Index / Health Care -SEC | 19.8.2010 | 637,98 | 7,37 | 31,30 |
FT | etf_assetclass_Sector Equity | 1,14 Mrd. | 56 484 | FT First Trust | 0,61 | Helsevesen | StrataQuant Health Care Index | 8.5.2007 | 135,22 | 3,02 | 17,23 |
FT | etf_assetclass_Sector Equity | 1,14 Mrd. | 507 720 | FT First Trust | 0,60 | Helsevesen | Nasdaq US Smart Pharmaceuticals Index | 20.9.2016 | 42,65 | 4,73 | 18,68 |
HA | Aksjer | 1,13 Mrd. | — | HA Harvest | 0,60 | Helsevesen | CSI Hong Kong Stock Connect Innovative Drug Index - CNY - Benchmark TR Net | 30.7.2025 | 0,91 | 0,00 | 0,00 |
PB | Aksjer | 1,13 Mrd. | 129 903 | PB Portfolio Building Block ETFs | 0,13 | Helsevesen | BITA Global Pharma and Biotech Select Index - Benchmark TR Net | 24.11.2025 | 30,06 | 4,93 | 20,32 |
VA | Aksjer | 1,06 Mrd. | 297 211 | VA VanEck | 0,36 | Helsevesen | MVIS US Listed Pharmaceutical 25 | 20.12.2011 | 114,96 | 4,92 | 18,95 |
AM | Aksjer | 1,04 Mrd. | 706 | AM Amundi | 0,30 | Helsevesen | MSCI World Index / Health Care -SEC | 19.8.2010 | 569,78 | 7,68 | 29,88 |
XT | Aksjer | 1,01 Mrd. | 9 990 | XT Xtrackers | 0,12 | Helsevesen | MSCI USA / Health Care -SEC | 12.9.2017 | 72,45 | 5,07 | 22,81 |
AM | Aksjer | 993,85 M | 11 232 | AM Amundi | 0,30 | Helsevesen | STOXX Europe 600 / Health Care (Capped) - SS | 21.3.2024 | 161,68 | 2,85 | 19,76 |
AM | Aksjer | 993,85 M | 286 | AM Amundi | 0,30 | Helsevesen | STOXX Europe 600 / Health Care (Capped) - SS | 21.3.2024 | 205,28 | 2,98 | 20,61 |
GX | Aksjer | 977,46 M | — | GX Global X | 0,59 | Helsevesen | FactSet Japan Bio & Med Technologies Index - JPY - Benchmark TR Net | 21.6.2021 | 1 739,46 | 1,90 | 19,17 |
IN | Aksjer | 964,83 M | 171 825 | IN Invesco | 0,40 | Helsevesen | S&P 500 Equal Weighted / Health Care -SEC | 1.11.2006 | 39,46 | 3,04 | 19,91 |
CS | Aksjer | 926,44 M | — | CS CSOP | 1,50 | Helsevesen | Hang Seng Biotech Index - HKD - Benchmark TR Net | 21.7.2021 | 3,75 | 3,33 | 23,96 |
| Aksjer | 897,71 M | — | WA Wanjia | 0,00 | Helsevesen | CSI Hong Kong Stock Connect Innovative Drug Index - CNY - Benchmark TR Net | 13.9.2024 | 1,62 | 3,45 | 24,62 |
AM | Aksjer | 832,49 M | 973 | AM Amundi | 0,30 | Helsevesen | STOXX Europe 600 / Health Care (Capped) - SS | 21.3.2024 | 135,43 | 2,85 | 19,76 |
IS | Aksjer | 776,7 M | 96 619 | IS iShares | 0,18 | Helsevesen | MSCI Europe Health Care 20/35 Capped Index - EUR | 17.11.2020 | 6,37 | 3,73 | 19,22 |
IS | Aksjer | 767,7 M | 60 576 | IS iShares | 0,18 | Helsevesen | MSCI World Health Care ESG Reduced Carbon Select 20 35 Capped Index - Benchmark TR Net | 17.10.2019 | 7,71 | 4,16 | 22,04 |
XT | Aksjer | 755,84 M | 11 670 | XT Xtrackers | 0,12 | Helsevesen | MSCI USA / Health Care -SEC | 12.9.2017 | 54,17 | 5,07 | 22,81 |
SP | Aksjer | 753,12 M | 13 630 | SP SPDR | 0,30 | Helsevesen | MSCI World Health Care 35/20 Capped Index - Benchmark TR Net | 28.2.2009 | 75,67 | 4,44 | 21,81 |
| Aksjer | 746,7 M | — | AB Aditya Birla Sun Life | 0,09 | Helsevesen | Nifty Healthcare Index - INR - Benchmark TR Gross | 19.10.2021 | 15,96 | 5,10 | 34,66 |
CA | Aksjer | 721,53 M | — | CA Cathay | 0,41 | Helsevesen | Bloomberg Barclays 15+ Year Healthcare Select Index - Benchmark TR Net | 23.4.2019 | 30,05 | 0,00 | 0,00 |
IS | Aksjer | 698,31 M | 6 922 | IS iShares | 0,46 | Helsevesen | STOXX Europe 600 / Health Care (Capped) - SS | 25.4.2001 | 119,38 | 3,63 | 19,15 |
GX | Aksjer | 666,05 M | — | GX Global X | 0,68 | Helsevesen | Solactive China Biotech Index | 24.7.2019 | 71,24 | 4,18 | 30,21 |
GX | Aksjer | 634,13 M | 25 730 | GX Global X | 0,68 | Helsevesen | Solactive China Biotech Index | 24.7.2019 | 67,82 | 4,18 | 30,21 |
SP | Aksjer | 626,32 M | 1 747 | SP SPDR | 0,18 | Helsevesen | MSCI Europe Health Care Index - EUR | 30.9.2001 | 241,22 | 3,73 | 19,22 |
CS | Aksjer | 615,18 M | — | CS China Southern | 0,65 | Helsevesen | Hang Seng Biotech Index - HKD - Benchmark TR Gross | 17.6.2022 | 1,10 | 2,98 | 21,35 |
DI | etf_assetclass_Leveraged/Inverse | 612,43 M | 437 748 | DI Direxion | 0,96 | Helsevesen | S&P Biotechnology Select Industry | 28.5.2015 | 228,99 | 0,00 | 0,00 |
IS | Aksjer | 592,49 M | 6 567 | IS iShares | 0,66 | Helsevesen | S&P Global 1200 Health Care Hedged to CAD Index - CAD | 12.4.2011 | 78,74 | 0,00 | 0,00 |
IN | Aksjer | 590,75 M | 1 126 | IN Invesco | 0,14 | Helsevesen | S&P Select Sector Capped 20% Health Care Index | 16.12.2009 | 895,37 | 5,12 | 22,97 |